Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax ...

A new poll shows an overhwhelming majority of Marylanders believe drug makers could reduce costs for prescription drugs ...

Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.

The pharma and life sciences industry faces a dynamic year ahead, driven by AI, sustainability, and evolving regulations. Stricter ESG reporting and economic uncertainty create new challenges. Success ...

The pharmaceutical industry argues that lower prices will have catastrophic effects on research and development, while other suggest that curbing drug prices will result in only modest cuts in the ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on the same day.

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

(Image Credits: Pixabay) Amid the growing burden of non-communicable diseases and ageing population, the pharmaceutical sector has thrived tremendously over the recent years. Industry leaders ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitementand skepticism ...

ReactWise Introduces AI-Powered Technology to Transform the Global Pharmaceutical Industry.London, United Kingdom, January 8, ...